Pilot Acute Safety Evaluation of Innocell™ Cancer Immunotherapy in Canine Subjects

BACKGROUND: We are developing cancer immunotherapy based on the use of autologous tumor tissue that has been rendered replication-incompetent but maintains phenotype and metabolic activity post-preparation. AIM: The aim of this study was to evaluate safety and tolerance to injection of the inactivat...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodrich, Raymond P., Weston, Jon, Hartson, Lindsay, Griffin, Lynn, Guth, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568153/
https://www.ncbi.nlm.nih.gov/pubmed/33102607
http://dx.doi.org/10.1155/2020/7142375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568153/
https://www.ncbi.nlm.nih.gov/pubmed/33102607
http://dx.doi.org/10.1155/2020/7142375

Ejemplares similares